Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • News
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
  • Support Us
  • About
    • Our Story
    • CIFAR 40
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Staff Directory
    • Equity, Diversity & Inclusion
  • fr
  • Home
  • Bio

Follow Us

post_content

Philip Hieter

Appointment

Fellow

Genetic Networks

Connect

Google Scholar

About

Biochemist Philip Hieter is recognized for his work on structural and regulatory proteins that ensure faithful segregation of chromosomes during cell division.

His work has also demonstrated and advocated the value of yeast and other model experimental organisms for understanding mechanisms of human disease.

Genes that maintain genome structure are often mutated in cancer. Hieter’s laboratory has established an extensive catalogue of genes required for genome stability in yeast, which provides a resource to identify cross-species, candidate human genes that are somatically mutated in cancer. The lab has developed a strategy to identify genes in yeast synthetic lethal interaction networks, based on yeast CIN genes whose human counterparts are mutated in cancers, as a means for identifying novel therapeutic targets for targeted killing of cancer cells.

Awards

  • Fellow, Royal Society of Canada, 2005
  • Fellow, Canadian Academy of Health Science, 2011
  • President, Genetics Society of America, 2012
  • Member, National Academy of Sciences, 2016
  • George W. Beadle Award, Genetics Society of America, 2018

Relevant Publications

  • Van Pel, D., Barrett I., Shimizu, Y., Sajeshd, B., Guppy, B., Pfeifer, T., McManus, K., Hieter, P. (2013). An Evolutionarily Conserved Synthetic Lethal Interaction Network Identifies FEN1 as a Broad-spectrum Target for Anticancer Therapeutic Development. PLoS Genetics 9(1):e1003254.

  • Bailey, M.L., O’Neil, N.J., van Pel, D.M., Solomon, D.A., Waldman, T., Hieter, P. (2014). Glioblastoma cells containing mutations in the cohesion component, STAG2, are sensitive to PARP inhibition. Mol Cancer Ther 13(3):724-32.

  • O’Neil, N.J., Moshgabadi, N., Hieter, P. (2014) Synthetic Cytotoxicity: Digenic Interactions with TEL1/ATM Mutations Reveal Sensitivity to Low Doses of Camptothecin. Genetics 197(2):611-23.

  • Duffy, S., Fam, H.K., Wang, Y., Styles, E., Kim, J-H., Ang, J.S., Singh, T., Larionov, V., Shah, S., Andrews, B., Boerkoel, C., Hieter, P. (2016). Over-expression screens identify conserved dosage chromosome instability genes in yeast and human cancer. Proc. Natl. Acad. Sci. USA 113:9967-76.

Institution

University of British Columbia

Department

Michael Smith laboratories

Education

  • PhD (Biochemistry), Johns Hopkins University

Country

Canada

Support Us

CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.

Donate Now
CIFAR header logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2023 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more